Members
PMC represents a broad spectrum of stakeholders including innovators, scientists, patients, providers, and payers.
Current Members
Paradigm shifts, especially in medicine, do not happen just because the science or new technologies suggest they should. Based on that assumption, some 20 institutions representing different sectors of the health system founded the Personalized Medicine Coalition in 2003 to improve upon medical paradigms that base treatment decisions exclusively on population averages.
With more than 200 active members, PMC membership is open but not limited to universities and academic medical centers, nonprofit research entities, relevant trade associations, patient advocacy groups, government officials (ex-officio), health care organizations, health care providers, payers, information technology companies, and research-based commercial companies that offer an array of products and services including research tools, diagnostic technologies and products, screening services, and therapeutic interventions.
- Clinical Laboratory Testing Services
- Diagnostic Companies
- Emerging Biotech/Pharmaceutical Companies
- Health Insurance Companies
- Industry & Trade Associations
- IT/Informatics Companies
- Large Biotech/Pharmaceutical Companies
- Patient Advocacy Groups
- Accelerated Cure Project for Multiple Sclerosis
- AiArthritis
- Alzheimer’s Foundation of America
- American Association of Kidney Patients
- American Cancer Society Cancer Action Network
- Colorectal Cancer Alliance
- Emily’s Entourage
- EveryLife Foundation for Rare Diseases
- Friends of Cancer Research
- Glioblastoma Foundation
- Global Liver Institute
- GO2 for Lung Cancer
- International Cancer Advocacy Network
- KRAS Kickers
- LUNGevity Foundation
- Malignant Hyperthermia Association of the United States (MHAUS)
- Multiple Myeloma Research Foundation
- National Alliance against Disparities in Patient Health
- National Alliance for Hispanic Health
- National Health Council
- One Cancer Place
- Sepsis Alliance
- SynGAP Research Fund
- TargetCancer Foundation
- Team Trevor
- The Assistance Fund
- Personalized Medicine Service Providers
- Research Tool Companies
- Research, Education, & Clinical Care Institutions
- AccelevirDx
- AdventHealth
- American Association for Cancer Research
- Arizona State University
- American Society of Health-System Pharmacists
- Association for Molecular Pathology
- Audubon Bioscience
- Bulgarian Association for Personalized Medicine
- Clarified Precision Medicine
- Colorado Center for Personalized Medicine
- CommonSpirit Health
- Culmination Bio
- Duke Center for Personalized Health Care
- European Infrastructure for Translational Medicine
- Hamad Medical Corporation
- Harvard Business School
- MaineHealth Accountable Care Organization
- Manchester University School of Pharmacy
- Mayo Clinic
- MD Anderson – Institute for Personalized Cancer Therapy
- Moffitt Cancer Center
- Morehouse School of Medicine
- National Foundation for Cancer Research
- Nicklaus Children’s Hospital Research Institute
- Endeavor Health
- Qatar Biobank
- Sanford Imagenetics, Sanford Health
- Teachers’ Retirement System of Kentucky
- University of Alabama, Birmingham
- The Jackson Laboratory
- UC Davis Mouse Biology Program
- Translational Genomics Research Institute
- University of Chicago
- University of Pennsylvania Health System
- University of Pittsburgh Medical Center
- University of South Florida Morsani College of Medicine
- Vanderbilt University Medical Center
- Strategic Partners
- Advancing Precision Medicine
- Arnold & Porter
- Avalere
- Bradford Power
- Bruce Quinn Associates
- Cambridge Healthtech Institute
- Catalytic Agency
- Clinical Transformation Partners
- ConText Research
- DeciBio
- Diaceutics
- Foley Hoag
- Foley & Lardner
- Genome Creative
- Goldbug Strategies
- Harbor Precision Genomics
- Health Advances
- Hogan Lovells
- Innovation Horizons
- Innovation Policy Solutions
- KPMG
- L.E.K. Consulting
- McDermott Will & Emery
- Morrison Foerster
- OncoRx Insights
- Prasanth Reddy MD MPH FACP
- Reservoir Communications
- Slone Partners
- Solaris RTC
- The Synergist
- Todd Strategy Group
- United States Pharmacopeial Convention
- Veranex
- Venture Capital